Skip to content

2ProPulse: value indication

Roughly what is an SME worth on what it filed? A range from its adjusted equity and its earnings, with your own assumptions, recalculated as you go.

Value indication

2ProPulse

BE 0686.744.657
NACE 70.200, Business and other management consultancy
latest balance sheet 31-12-2024indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€405,698 to €518,681

Midpoint €452,775 · 50% capitalised earnings, 50% adjusted equity

Adjusted equity €246,482
Capitalised earnings €564,914 to €790,880
Indication €405,698 to €518,681

Your assumptions

Capitalised earnings
%

The return a buyer expects on the money put in. Higher for more risk. The range also computes with 2 points more and less.

Adjust the equity
Blend
50%
Optional: your own multiple

Checked holds no market prices, so it suggests no multiple. If you have one from a transaction or a study, the tool applies it to the filed EBITDA less the net financial debt.

Adjusted equity

balance sheet 31-12-2024
Equity (10/15)
€246,482
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€246,482

Capitalised earnings

net result for the year (9904)
2024
€90,049
2023
€80,065
2022
€67,151
2021
€22,964
2020
-€7,721
Average result
€79,088
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€564,914 / €659,067 / €790,880

What this indication leaves out

  • Market prices and comparable transactions: Checked does not hold them.
  • Anything after the latest accounts, and items off the balance sheet (guarantees, leases, disputes).
  • The real value of buildings, stock and receivables: enter your own revaluation or adjustment.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale.

For a valuation to decide on: a company auditor or a certified accountant.

Source: filed annual accounts (NBB), latest balance sheet at 31 December 2024. Prepared on 28 September 2026 via checked.be. Indication, not a valuation or advice.